FineTech is a High-Tech chemical synthesis company dedicated to serve the growing needs of the Pharma industry including Ethical, Generic and Biotech companies with The Chemical Master Key™ approach. Master Key provides Company's customers with opportunities from NCE development, through all phases of clinical trials, to the commercial cGMP production of advanced intermediates and API's.

Company was acquired by Opko Health, Inc.